SI1617834T1 - Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe - Google Patents

Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe

Info

Publication number: SI1617834T1
Authority: SI; Slovenia
Prior art keywords: lactate; potassium; pharmaceutical composition; lactic acid; composition containing
Prior art date: 2003-05-01

Application number

SI200430136T

Other languages

English (en)

Inventor

Xavier M Leverve

Mustafa No Iqbal

Original Assignee

Innogene Kalbiotech Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-01

Filing date

2004-03-22

Publication date

2007-02-28

2004-03-22 Application filed by Innogene Kalbiotech Pte Ltd filed Critical Innogene Kalbiotech Pte Ltd

2007-02-28 Publication of SI1617834T1 publication Critical patent/SI1617834T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Surgery (AREA)
Child & Adolescent Psychology (AREA)

SI200430136T 2003-05-01 2004-03-22 Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe SI1617834T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ID20030213		2003-05-01
EP04722501A EP1617834B1 (en)	2003-05-01	2004-03-22	Use of a pharmaceutical composition containing lactic acid or lactate and potassium for treating brain edema or brain injury
PCT/SG2004/000066 WO2004096204A1 (en)	2003-05-01	2004-03-22	Lactate containing pharmaceutical composition and uses thereof

Publications (1)

Publication Number	Publication Date
SI1617834T1 true SI1617834T1 (sl)	2007-02-28

Family

ID=33397627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200430136T SI1617834T1 (sl)	2003-05-01	2004-03-22	Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe

Country Status (30)

Country	Link
US (1)	US20080125488A1 (sl)
EP (2)	EP1759695A1 (sl)
JP (1)	JP5037937B2 (sl)
KR (1)	KR101076059B1 (sl)
CN (1)	CN1777416B (sl)
AR (1)	AR043670A1 (sl)
AT (1)	ATE340568T1 (sl)
AU (1)	AU2004233904B2 (sl)
BR (1)	BRPI0409867A (sl)
CA (1)	CA2523740C (sl)
CY (1)	CY1105880T1 (sl)
DE (1)	DE602004002585T2 (sl)
DK (1)	DK1617834T3 (sl)
EA (2)	EA010948B1 (sl)
ES (1)	ES2274438T3 (sl)
IL (1)	IL171721A (sl)
MA (1)	MA27845A1 (sl)
MX (1)	MXPA05011532A (sl)
MY (1)	MY140382A (sl)
NO (1)	NO20055652L (sl)
NZ (1)	NZ543201A (sl)
PL (1)	PL1617834T3 (sl)
PT (1)	PT1617834E (sl)
SG (1)	SG160217A1 (sl)
SI (1)	SI1617834T1 (sl)
TN (1)	TNSN05275A1 (sl)
TW (1)	TWI290045B (sl)
UA (1)	UA86937C2 (sl)
WO (1)	WO2004096204A1 (sl)
ZA (1)	ZA200509684B (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007114791A1 (en) *	2006-04-03	2007-10-11	Innogene Kalbiotech Pte Ltd	Lactate and calcium containing pharmaceutical composition and uses thereof
ES2482190T3 (es)	2007-03-30	2014-08-01	Laccure Ab	Uso de oligómeros de ácido láctico en el tratamiento de infecciones ginecológicas
KR20120015295A (ko) *	2009-03-26	2012-02-21	풀매트릭스 인코퍼레이티드	점막 내층의 생물물리학적 성질의 변경을 위한 구연산 칼슘 및 젖산 칼슘 제형
RU2577698C2 (ru)	2009-03-26	2016-03-20	Пулмэтрикс, Инк.	Сухие порошкообразные составы и способы лечения легочных заболеваний
CA2809666C (en)	2010-08-30	2020-09-22	Michael M. Lipp	Dry powder formulations and methods for treating pulmonary diseases
US20130164338A1 (en)	2010-08-30	2013-06-27	Pulmatrix, Inc.	Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
RU2640921C2 (ru)	2010-09-29	2018-01-12	Пулмэтрикс, Инк.	Катионы одновалентных металлов сухих порошков для ингаляций
ES2710537T3 (es)	2010-09-29	2019-04-25	Pulmatrix Operating Co Inc	Polvos secos catiónicos
ES2396650B2 (es) *	2011-07-21	2013-07-16	Universidad Complutense De Madrid	Uso de una composición en la elaboración de una solución de diálisis para el tratamiento de las enfermedades cerebrovasculares mediante diálisis peritoneal.
CA2865972C (en)	2012-02-29	2022-01-04	Pulmatrix, Inc.	Inhalable dry powders
BR112014027983B1 (pt)	2012-05-08	2022-05-24	Aeromics, Inc	Uso de inibidores de aquaporina seletivos
BR112015002270B1 (pt) *	2012-08-01	2020-02-11	Purac Biochem B.V.	Pó de lactato e método para a preparação do mesmo
US9808031B2 (en)	2012-10-25	2017-11-07	Run Them Sweet Llc	Systems and methods to estimate nutritional needs of human and other patients
US9897609B2 (en)	2012-10-25	2018-02-20	Run Them Sweet, LLC	Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs
US9232815B2 (en)	2012-10-25	2016-01-12	Run Them Sweet, LLC	Blood lactate range targets and nutritional formulations and protocols to support patients
EP2769630B1 (en)	2013-02-26	2016-04-27	Purac Biochem N.V.	Improved nisin production process
EP2754356A1 (en)	2013-01-15	2014-07-16	Purac Biochem N.V.	Improved nisin production process
MX2015013845A (es)	2013-04-01	2016-05-09	Pulmatrix Inc	Polvos secos de tiotropio.
WO2015069961A1 (en)	2013-11-06	2015-05-14	Aeromics, Llc	Novel prodrug salts
WO2015182815A1 (ko) *	2014-05-26	2015-12-03	한국생명공학연구원	Ndrg3 발현 또는 활성 촉진제를 유효성분으로 함유하는 허혈성 질환 예방 및 치료용 약학적 조성물
PL3481216T5 (pl)	2016-07-07	2024-07-01	Dsm Ip Assets B.V.	Sposób otrzymywania izolatu białka rzepakowego i otrzymany za jego pomocą izolat białka rzepakowego
US10124021B2 (en) *	2016-12-23	2018-11-13	Andrew L. Gostine	Intravenous fluid
WO2020163654A1 (en) *	2019-02-06	2020-08-13	Paul Leo Mcgrane	Biologically modified vascular grafts for improved bypass surgery outcomes
WO2021150259A1 (en) *	2020-01-24	2021-07-29	Barkey Daniel Q	Compositions and methods for weight loss
WO2023114375A2 (en) *	2021-12-16	2023-06-22	Alveolus Bio, Inc.	Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease
CN116531358A (zh) *	2023-06-06	2023-08-04	中国医科大学附属第一医院	含乳酸盐缓冲体系在制备心力衰竭治疗药物中的应用
EP4502147A1 (en)	2023-07-31	2025-02-05	M2Rlab SL	Method for the polarization of cells to a new m2 phenotype and uses of said m2-polarized cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987003808A1 (en) *	1985-12-18	1987-07-02	Veech Richard L	Fluid therapy with l-lactate and/or pyruvate anions
EP0441119A3 (en) *	1990-01-09	1992-10-14	Richard D. Levere	The use of l-arginine in the treatment of hypertension and other vascular disorders
US5248507A (en) *	1991-05-31	1993-09-28	Board Of Regents, The University Of Texas System	Hypertonic isochloremic formulation for circulatory shock
JPH05255092A (ja) *	1992-03-17	1993-10-05	Kyowa Hakko Kogyo Co Ltd	腸管洗浄用組成物
ATE199626T1 (de) *	1993-06-04	2001-03-15	Biotime Inc	Plasma-artige lösung
US6306828B1 (en) *	1995-04-06	2001-10-23	Baxter International, Inc.	Enantiomerically-enhanced nutritional energy substrates
JPH0940554A (ja) *	1995-08-03	1997-02-10	Nissho Corp	グルタミンを含む輸液及びその製造方法
WO1998008500A1 (en) *	1996-08-26	1998-03-05	Board Of Regents, The University Of Texas System	Hypertonic arginine compositions and methods
US6436444B1 (en) *	1997-09-26	2002-08-20	Ecolab Inc.	Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection
CN1068778C (zh) *	1998-05-15	2001-07-25	赵超英	救治用的药物组合物及其制备方法
RU2136293C1 (ru) *	1998-08-04	1999-09-10	Открытое акционерное общество "Биохимик"	Способ получения заменителя плазмы крови

2004
- 2004-03-22 US US10/555,196 patent/US20080125488A1/en not_active Abandoned
- 2004-03-22 PL PL04722501T patent/PL1617834T3/pl unknown
- 2004-03-22 EP EP06121128A patent/EP1759695A1/en not_active Withdrawn
- 2004-03-22 DE DE602004002585T patent/DE602004002585T2/de not_active Expired - Lifetime
- 2004-03-22 SI SI200430136T patent/SI1617834T1/sl unknown
- 2004-03-22 AU AU2004233904A patent/AU2004233904B2/en not_active Ceased
- 2004-03-22 AT AT04722501T patent/ATE340568T1/de active
- 2004-03-22 CN CN2004800110612A patent/CN1777416B/zh not_active Expired - Fee Related
- 2004-03-22 MX MXPA05011532A patent/MXPA05011532A/es active IP Right Grant
- 2004-03-22 NZ NZ543201A patent/NZ543201A/en not_active IP Right Cessation
- 2004-03-22 EA EA200501675A patent/EA010948B1/ru not_active IP Right Cessation
- 2004-03-22 PT PT04722501T patent/PT1617834E/pt unknown
- 2004-03-22 SG SG200717319-8A patent/SG160217A1/en unknown
- 2004-03-22 EP EP04722501A patent/EP1617834B1/en not_active Expired - Lifetime
- 2004-03-22 MY MYPI20040998A patent/MY140382A/en unknown
- 2004-03-22 JP JP2006508059A patent/JP5037937B2/ja not_active Expired - Fee Related
- 2004-03-22 ES ES04722501T patent/ES2274438T3/es not_active Expired - Lifetime
- 2004-03-22 CA CA2523740A patent/CA2523740C/en not_active Expired - Fee Related
- 2004-03-22 AR ARP040100933A patent/AR043670A1/es not_active Application Discontinuation
- 2004-03-22 DK DK04722501T patent/DK1617834T3/da active
- 2004-03-22 WO PCT/SG2004/000066 patent/WO2004096204A1/en not_active Ceased
- 2004-03-22 EA EA200801073A patent/EA013846B1/ru not_active IP Right Cessation
- 2004-03-22 UA UAA200511417A patent/UA86937C2/ru unknown
- 2004-03-22 BR BRPI0409867-6A patent/BRPI0409867A/pt not_active IP Right Cessation
- 2004-03-23 TW TW093107705A patent/TWI290045B/zh not_active IP Right Cessation
2005
- 2005-10-24 TN TNP2005000275A patent/TNSN05275A1/en unknown
- 2005-11-01 KR KR1020057020706A patent/KR101076059B1/ko not_active Expired - Fee Related
- 2005-11-01 IL IL171721A patent/IL171721A/en active IP Right Grant
- 2005-11-30 NO NO20055652A patent/NO20055652L/no not_active Application Discontinuation
- 2005-11-30 ZA ZA200509684A patent/ZA200509684B/en unknown
- 2005-12-01 MA MA28632A patent/MA27845A1/fr unknown
2006
- 2006-12-21 CY CY20061101847T patent/CY1105880T1/el unknown

Also Published As

Publication number	Publication date
EP1759695A1 (en)	2007-03-07
BRPI0409867A (pt)	2006-05-16
IL171721A (en)	2012-05-31
TWI290045B (en)	2007-11-21
CA2523740A1 (en)	2004-11-11
PT1617834E (pt)	2007-01-31
UA86937C2 (ru)	2009-06-10
NO20055652D0 (no)	2005-11-30
EA013846B1 (ru)	2010-08-30
ZA200509684B (en)	2007-03-28
MXPA05011532A (es)	2006-05-31
AU2004233904A1 (en)	2004-11-11
EA200801073A1 (ru)	2008-08-29
JP5037937B2 (ja)	2012-10-03
MY140382A (en)	2009-12-31
EA010948B1 (ru)	2008-12-30
TW200423923A (en)	2004-11-16
ATE340568T1 (de)	2006-10-15
NO20055652L (no)	2006-02-01
SG160217A1 (en)	2010-04-29
TNSN05275A1 (en)	2007-07-10
AR043670A1 (es)	2005-08-03
DE602004002585D1 (de)	2006-11-09
AU2004233904B2 (en)	2009-11-12
CN1777416A (zh)	2006-05-24
EP1617834A1 (en)	2006-01-25
KR20050119701A (ko)	2005-12-21
PL1617834T3 (pl)	2007-02-28
ES2274438T3 (es)	2007-05-16
CN1777416B (zh)	2012-11-07
EA200501675A1 (ru)	2006-06-30
HK1085942A1 (en)	2006-09-08
US20080125488A1 (en)	2008-05-29
EP1617834B1 (en)	2006-09-27
DK1617834T3 (da)	2007-02-05
CA2523740C (en)	2012-05-15
CY1105880T1 (el)	2011-02-02
KR101076059B1 (ko)	2011-10-21
NZ543201A (en)	2007-05-31
MA27845A1 (fr)	2006-04-03
DE602004002585T2 (de)	2007-10-25
WO2004096204A1 (en)	2004-11-11
JP2006525324A (ja)	2006-11-09

Publication	Publication Date	Title
PL1617834T3 (pl)	2007-02-28	Kompozycja farmaceutyczna zawierająca mleczan i jej zastosowania
EP1737453A4 (en)	2008-11-26	METHOD FOR THE USE OF IMMUNOMODULATORY COMPOUNDS AND COMPOSITIONS CONTAINING THEREOF FOR THE TREATMENT AND SUPPLY OF SKIN DISEASES OR DISORDERS
EP1804761A4 (en)	2008-09-17	COMPOSITIONS AND METHODS OF TREATING SKIN DISORDER
PL1673104T5 (pl)	2023-03-06	Dostarczanie związków terapeutycznych do mózgu i do innych tkanek
EP1638605A4 (en)	2009-08-12	DISTRIBUTION OF THERAPEUTIC COMPOUNDS TO THE BRAIN AND OTHER TISSUE
HUS1500021I1 (hu)	2017-04-28	1,2,4-oxadiazol-benzoesav vegyületek és alkalmazásuk nonszensz szupresszióra és a betegség kezelésére
AU2003300939A8 (en)	2004-07-29	Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
IL179616A0 (en)	2007-05-15	Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
AU2003278775A8 (en)	2005-04-27	Porifera-based therapeutic compositions for treating and preventing skin diseases
WO2008105088A1 (ja)	2008-09-04	脊髄損傷治療薬剤
MY147404A (en)	2012-11-30	Process for preparation of n-benzoyl-staurosporine
EP1753425A4 (en)	2009-08-05	THERAPEUTIC AGENT COMPRISING A NICOTINIC ACID OR DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF CANCER
WO2008130319A3 (en)	2008-12-18	Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
EP1697302A4 (en)	2011-04-27	COMPOUNDS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF BONE INJURIES AND METABOLIC DISORDERS
PL378197A1 (pl)	2006-03-06	Pochodne kwasów indenokarboksylowych oraz ich zastosowanie do leczenia i zapobiegania cukrzycy i dyslipidemii
IL179039A0 (en)	2007-03-08	Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
TWI345980B (en)	2011-08-01	Pharmaceutical compositions for preventing or treating injuries of brain tissue
GB0310147D0 (en)	2003-06-04	A composition for use in the treatment of a skin condition in a subject
AU2003266621A8 (en)	2004-04-19	Medicinal composition for treatment for or prevention of visceral pain
GB0304871D0 (en)	2003-04-09	Formulation for treatment of paralizing pain stiffness
ZA200610028B (en)	2008-08-27	Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
AU2004907310A0 (en)	2005-01-13	PGEI Composition for treatment of vascular disease and or vascular injury
HK1101801A (en)	2007-10-26	Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
SI1585513T1 (sl)	2006-10-31	Uporaba dokosaheksaenojske kisline kot aktivne snovi za zdravljenje lipodistrofije
GB0325259D0 (en)	2003-12-03	Therapeutic agents for the treatment of bone conditions